WallStreetZenWallStreetZen

NASDAQ: SCTX
Scribe Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Scribe Therapeutics revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $2.2M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SCTX annual revenue was $51.2M, with 86.7% growth year-over-year.

SCTX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when SCTX announces revenue.

SCTX Revenue History By Year

SCTX Yearly RevenueSCTX RevenueSCTX ChangeSCTX Revenue Growth
2025-12-31$51.17M$23.76M+86.68%
2024-12-31$27.41MN/AN/A

1 of 1

Scribe Therapeutics Revenue FAQ

What was SCTX's revenue last quarter?

Scribe Therapeutics (NASDAQ: SCTX) reported Q1 2026 revenue of $2.23 million up 86.96% year over year. In the same quarter last year, Scribe Therapeutics's revenue was $17.13 million.

What was Scribe Therapeutics's revenue in 2025?

Scribe Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $51.17 million, a 86.68% increase year over year.

How much does Scribe Therapeutics make in a day?

Based on Scribe Therapeutics annual revenue for the past one years, SCTX makes an average of $140,202.74 per day.

What was Scribe Therapeutics's annual revenue growth in the past year?

As of Q3 2026, Scribe Therapeutics's revenue has grown null year over year. Scribe Therapeutics's revenue in the past year totaled N/A.

How much does Scribe Therapeutics make in a year?

Scribe Therapeutics's revenue by year for the past one years is:
  • Scribe Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $51.17 million, a 86.68% increase year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.